Literature DB >> 19858366

LKB1 and mammalian target of rapamycin as predictive factors for the anticancer efficacy of metformin.

Regan M Memmott, Phillip A Dennis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19858366     DOI： 10.1200/JCO.2009.25.3963

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  19 in total

1.  Metformin impairs the growth of liver kinase B1-intact cervical cancer cells.

Authors:  Xuxian Xiao; Qiongqiong He; Changming Lu; Kaitlin D Werle; Rui-Xun Zhao; Jianfeng Chen; Ben C Davis; Rutao Cui; Jiyong Liang; Zhi-Xiang Xu
Journal:  Gynecol Oncol       Date:  2012-06-24       Impact factor: 5.482

2.  Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator.

Authors:  Kuen-Haur Lee; En-Chi Hsu; Jih-Hwa Guh; Hsiao-Ching Yang; Dasheng Wang; Samuel K Kulp; Charles L Shapiro; Ching-Shih Chen
Journal:  J Biol Chem       Date:  2011-09-14       Impact factor: 5.157

3.  The BATTLE to personalize lung cancer prevention through reverse migration.

Authors:  Kathryn A Gold; Edward S Kim; J Jack Lee; Ignacio I Wistuba; Carol J Farhangfar; Waun Ki Hong
Journal:  Cancer Prev Res (Phila)       Date:  2011-07

4.  Reduction behavior induced by HL010183, a metformin derivative against the growth of cutaneous squamous cell carcinoma.

Authors:  Guoying Miao; Baoguo Liu; Xiaohui Guo; Xike Zhang; Gui-Jing Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 5.  Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.

Authors:  Małgorzata Muc-Wierzgoń; Ewa Nowakowska-Zajdel; Sylwia Dzięgielewska-Gęsiak; Teresa Kokot; Katarzyna Klakla; Edyta Fatyga; Elżbieta Grochowska-Niedworok; Dariusz Waniczek; Janusz Wierzgoń
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

6.  Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions.

Authors:  Alejandro Vazquez-Martin; Eugeni López-Bonetc; Sílvia Cufí; Cristina Oliveras-Ferraros; Sonia Del Barco; Begoña Martin-Castillo; Javier A Menendez
Journal:  Drug Resist Updat       Date:  2011-05-19       Impact factor: 18.500

7.  Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma.

Authors:  Anne Wynn; Albert Vacheron; Jeffrey Zuber; Solomon S Solomon
Journal:  Am J Med Sci       Date:  2019-07-04       Impact factor: 2.378

8.  Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis.

Authors:  Kavita Bhalla; Bor Jang Hwang; Ruby E Dewi; William Twaddel; Olga G Goloubeva; Kwok-Kin Wong; Neeraj K Saxena; Shyam Biswal; Geoffrey D Girnun
Journal:  Cancer Prev Res (Phila)       Date:  2012-03-31

Review 9.  Metformin and cancer: new applications for an old drug.

Authors:  Taxiarchis V Kourelis; Robert D Siegel
Journal:  Med Oncol       Date:  2011-02-08       Impact factor: 3.064

10.  Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers.

Authors:  Monique B Nilsson; Huiying Sun; Lixia Diao; Pan Tong; Diane Liu; Lerong Li; Youhong Fan; Alissa Poteete; Seung-Oe Lim; Kathryn Howells; Vincent Haddad; Daniel Gomez; Hai Tran; Guillermo Armaiz Pena; Lecia V Sequist; James C Yang; Jing Wang; Edward S Kim; Roy Herbst; J Jack Lee; Waun Ki Hong; Ignacio Wistuba; Mien-Chie Hung; Anil K Sood; John V Heymach
Journal:  Sci Transl Med       Date:  2017-11-08       Impact factor: 17.956
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.